Invitrogen™ Rat CD-80 ELISA Kit

Ref.: BL-RE-106162Manufacturer ref.: ERA6RBX5 5 x 96 tests
€2,950.00 excl. VAT

Rat CD-80 quantitates rat CD-80 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat CD-80.

Accession number
Antigène B7-1 d’activation ; protéine B7 ; protéine B7 ; B7.1 ; B71 ; B7-1 ; protéine B7-1 ; antigène B7 d’activation des lymphocytes B ; Cd28l ; CD28LG ; CD28LG1 ; CD80 ; Cd80, un homologue chez le rat du ligand CD28/CTLA - 4 humain (B7-1) ; antigène CD80 ; antigène CD80 ; antigène CD80 (ligand 1 d’antigène CD28 1, antigène B7-1) ; molécule Cd80 ; précurseur protéique CD80 ; facteur costimulatoire CD80 ; variante de la molécule de costimulation IgV-CD80 ; contre-récepteur CTLA-4 B7.1 ; LAB7 ; Ly53 ; Ly-53 ; MIC17 ; sCD 80 ; SCD80 ; CD 80 soluble ; CD80 soluble ; molécule de co-stimulation des cellules T ; protéine de co-stimulation des cellules T B7-1 ; antigène d’activation des lymphocytes T CD80 ; TS/A-1 ; TSA1
Dose range
1.23 to 300 pg/ml
Sensitivity of the dosage
1.23 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Rat CD-80 quantitates rat CD-80 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat CD-80.

Rat CD-80 quantitates rat CD-80 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat CD-80.

CD80 (B7-1) and CD86 (B7-2) are critical CD28 costimulation molecule ligands of T cells and CTLA-4 inhibitor receptor (CD152). Both B7 molecules are expressed on professional antigen-presenting cells and are essential for T cell activation. These two molecules can also replace one another in this process. CD80 is rapidly induced on the surface of B cells activated in vitro, with B cell lines transformed by the Epstein Barr virus (EBV), with Burkitt lymphoma cell lines, with newly isolated follicular B lymphoma cells, T cells, and monocytes. The B7-1 B-Dactivation antigen provides regulatory signals for T-cell lymphocytes as a result of binding to CD28 and CTLA4 ligands in T cells. Diseases associated with CD80 protein dysfunction include epidermoid carcinoma of the gallbladder and myocarditis.

Sensitivity

Sensitivity of the dosage: 1.23 ng/ml.

Measurement range

Dose range: 1.23 to 300 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: CD80 (B7-1).

Samples

Sample type: Plasma, Serum, Surnatant (plasma volume, 50 µl; supernatant, 50 µl; serum, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17165899
Specifications
Accession numberAntigen B7-1 d-activation; protein B7; protein B7; B7.1; B71; B7-1; protein B7-1; antigen B7 of activation of B lymphocytes; Cd28l; CD28LG; CD28LG1 ; CD80; Cd80, a homologous rat CD28/CTLA - 4 human (B7-1) ; CD80 antigen ; CD80 antigen ; CD80 antigen (ligand 1 d)
Dose range1.23 to 300 pg/ml
Sensitivity of the dosage1.23 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Gene symbol(s)CD80
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetCD80 (B7-1)
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 µl; supernatant, 50 µl; serum, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.ERA6RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.